The Characteristics of Different Personal Lancets on Blood Volume and Perceived Pain in Patients With Diabetes Mellitus

Summary

A randomized single-blind study with the use of different lancing devices equipped with personal lancets to determine and to compare the amount of capillary blood volume and perceived pain after a single lancing of the fingertip.

Conditions

• Diabetes Mellitus, Type 1
• Diabetes Mellitus, Type 2

Interventions

DEVICE

Droplet lancing device (HTL-Strefa S.A.)

DEVICE

Microlet 2 lancing device (Bayer)

DEVICE

OneTouch Delicia lancing device (LifeScan)

DEVICE

ReliOn lancing device (ReliOn)

DEVICE

Accu-Chek Softclix lancing device (Roche)

DEVICE

BGStar lancing device (Sanofi Aventis)

DEVICE

Ultra-Fine 33G lancets (BD)

DEVICE

Droplet 33G lancets (HTL-Strefa S.A.)

DEVICE

OneTouch Delicia Extra Fine 33G lancets (LifeScan)

DEVICE

HaemoFine 33G lancets (HTL-Strefa S.A.)

DEVICE

Softclix 28 G lancets (Roche)

DEVICE

ReliOn Ultra-Thin Plus 33G lancets (ReliOn)

DEVICE

GlucoJect Dual S lancing device (Menarini)

DEVICE

Microlet 28G lancets (Bayer)

DEVICE

BGStar Ultra-Thin 33G lancets (Sanofi Aventis)

Sponsors & Collaborators

• HTL-Strefa S.A.

  lead INDUSTRY

Study Design

Allocation

RANDOMIZED

Purpose

OTHER

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

75 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2013-08-31

Primary Completion

2013-08-31

Completion

2013-08-31